⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | Canara Robeco Manufacturing Fund - Growth - Direct Plan | HDFC Pharma and Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | Canara Robeco MF | HDFC MF |
| Category | Equity - Thematic Fund - Other | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹13.30 (30 Oct 2026) | ₹21.95 (30 Oct 2026) |
| Rating | ★★★ | ★★★★★ |
| Benchmark | Nifty India Manufacturing - TRI | BSE Health Care - TRI |
| Fund Manager | Pranav Gokhale | Nikhil Mathur |
| Inception | 11 Mar 2024 | 04 Oct 2023 |
| Returns | ||
| 1Y | 2.35% | 22.64% |
| 3Y | — | 30.41% |
| 5Y | — | — |
| Since Inception | 12.09% | 29.15% |
| Risk | ||
| 18.54 | 14.07 | |
| 1.09 | 0.59 | |
| 0.52 | 1.59 | |
| 3.20 | 21.67 | |
| 1.02 | 3.48 | |
| -11.50% | -9.23% | |
| Costs | ||
| Expense Ratio | 0.96% | 1.03% |
| Exit Load | 1% on or before 365D, Nil after 365D | 1% on or before 30D, Nil after 30D |
| Min SIP | ₹1,000 | ₹100 |
| Min Lumpsum | ₹5,000 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
Canara Robeco…93%
HDFC MF93%
7.0%Only 7.0% of holdings by weight are common between Canara Robeco MF and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingCanara Robeco MFHDFC MF
Divi's Laboratories Ltd.2.60%9.39%
Rubicon Research Ltd.3.05%2.52%
Torrent Pharmaceuticals Ltd.1.83%3.65%
Category context: Equity vs Equity. Open the full Screener →